Annovis Bio, Inc. (ANVS)
NYSE · Healthcare
Annovis Bio, Inc. Income Statement 2020–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | — | — | — | — | — | — |
| Profitability | ||||||
| Operating Income | -29.7M | -26.7M | -45.0M | -25.5M | -14.5M | -6.6M |
| EBITDA | — | — | — | — | — | — |
| Net Income | -28.9M | -24.6M | -56.2M | -25.3M | -14.5M | -5.5M |
| Per Share Data | ||||||
| EPS (diluted) | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 21M | 12M | 9M | 8M | 8M | 6M |
Annovis Bio, Inc. Income Statement — FAQ
Annovis Bio, Inc. (ANVS) income statement over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ANVS's income statement history?
The chart and table above show Annovis Bio, Inc.'s income statement by year and by quarter, including the growth rate.